POSTABSORPTIVE URINARY HYDROXYPROLINE TEST IN PATIENTS WITH METASTATIC BONE-DISEASE FROM BREAST-CANCER

被引：19
作者：
NIELL, HB [1 ]
PALMIERI, GM [1 ]
NEELY, CL [1 ]
MCDONALD, MW [1 ]
机构：
[1] UNIV TENNESSEE, CTR HLTH SCI, DEPT NUCL MED, MEMPHIS, TN 38163 USA
来源：
ARCHIVES OF INTERNAL MEDICINE | 1981年 / 141卷 / 11期
关键词：
D O I：
10.1001/archinte.141.11.1471
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
Postabsorptive urine hydroxyproline (HYPRO) excretion (spot HYPRO test) was compared with the 24 h urine excretion of HYPRO in 45 patients with breast cancer and 9 normal subjects on a low-gelatin diet. A good correlation was observed between the results of these 2 tests in both groups. Patients with skeletal metastasis showed a higher spot HYPRO value than those without bone involvement and the number of lesions by bone scanning correlated with the values of spot HYPRO. In 20 of 22 patients with bone metastasis followed up for 3-19 mo., spot HYPRO values correlated well with the evolution of bone disease. The spot HYPRO test is a simple, inexpensive and accurate method for the diagnosis and follow-up of patients with skeletal metastasis from breast cancer.
引用
收藏
页码：1471 / 1473
页数：3
相关论文
共 50 条
  • [41] EFFECT OF LEVODOPA ON BONE PAIN IN METASTATIC BREAST-CANCER
    CLAVEL, M
    CHEIXSER.F
    POMMATAU, E
    LYON MEDICAL, 1974, 232 (18): : 531 - 536
  • [42] FAILURE OF INDOMETHACIN TO REDUCE HYDROXYPROLINE EXCRETION OR HYPERCALCEMIA IN PATIENTS WITH BREAST-CANCER
    COOMBES, RC
    NEVILLE, AM
    BONDY, PK
    POWLES, TJ
    PROSTAGLANDINS, 1976, 12 (06): : 1027 - 1035
  • [43] VALUE OF ADRENALECTOMY IN PATIENTS WITH METASTATIC BREAST-CANCER
    DAO, TL
    SURGICAL CLINICS OF NORTH AMERICA, 1978, 58 (04) : 801 - 808
  • [44] POLYCHEMOTHERAPEUTIC TREATMENT OF PATIENTS WITH METASTATIC BREAST-CANCER
    BALAZS, M
    TUSKE, M
    ACTA MEDICA HUNGARICA, 1986, 43 (04) : 407 - 411
  • [45] HEPATOTOXICITY OF HYCANTHONE IN PATIENTS WITH METASTATIC BREAST-CANCER
    HAQ, MM
    LEGHA, SS
    WISEMAN, CW
    BODEY, GP
    CANCER TREATMENT REPORTS, 1980, 64 (8-9): : 929 - 932
  • [46] URINARY ESTROGENS AND PREGNANDIOL IN BREAST-CANCER PATIENTS
    ZAKI, K
    ELKHARADLY, M
    ELFARAS, A
    NOUR, H
    KAMEL, NIM
    ENDOKRINOLOGIE, 1982, 79 (01): : 49 - 56
  • [47] PHARMACOKINETICS OF CLODRONATE IN PATIENTS WITH METASTATIC BREAST-CANCER
    PENTIKAINEN, PJ
    ELOMAA, I
    NURMI, AK
    KARKKAINEN, S
    INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY AND THERAPEUTICS, 1989, 27 (05) : 222 - 228
  • [48] CALCIUM-LOADING-TEST AND BONE-DISEASE IN PATIENTS WITH NEPHROLITHIASIS
    LINDERGARD, B
    COLLEEN, S
    MANSSON, W
    RADEMARK, C
    ROGLAND, B
    KIDNEY INTERNATIONAL, 1983, 24 (03) : 425 - 425
  • [49] PHARMACOKINETICS OF CLODRANATE IN PATIENTS WITH METASTATIC BREAST-CANCER
    PENTIKAINEN, PJ
    ELOMAA, I
    NURMI, AK
    KARKKAINEN, S
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 1986, 39 (02) : 218 - 218
  • [50] CALCIUM-LOADING TEST AND BONE-DISEASE IN PATIENTS WITH UROLITHIASIS
    LINDERGARD, B
    COLLEEN, S
    MANSSON, W
    RADEMARK, C
    ROGLAND, B
    PROCEEDINGS OF THE EUROPEAN DIALYSIS AND TRANSPLANT ASSOCIATION, 1983, 20 : 460 - 465
12345